For superficial atrophic gastritis, the following treatments are available: 1. symptomatic treatment with drugs that promote gastrointestinal motility, commonly used are morpholine or itopride tablets. 2. drugs that promote mucosal repair, such as rehabilitation new liquid or thioglycollate suspension. 3. drugs that promote gastric juice secretion, such as multi-enzyme tablets or pancreatic enzyme granules, etc. Generally for atrophic gastritis, often spoken for non-atrophic gastritis, is mainly characterized by reduced secretion of the gastric glands, which leads to gastrointestinal dysfunction and digestive malfunction. Atrophic gastritis also requires perfect testing for H. pylori, and if it is positive and DPM > 700, anti-H. pylori medication is required. Clinically, there are commonly used drugs of gastric triplet or gastric quadruplet, which are usually treated for about two weeks.